Early surfactant administration protects against lung dysfunction in a mouse model of ARDS

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 5 28-5, 2003, Pages

  Rasaiah, Vijay P A ^a   Malloy, Jaret L ^a   Lewis, James F ^a   Veldhuizen, Ruud A W ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Acute respiratory distress syndrome; Mechanical ventilation; Sepsis

Indexed keywords

INTERLEUKIN 6; LIPID; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFECTION PREVENTION; LUNG COMPLIANCE; LUNG DISEASE; LUNG PARENCHYMA; LUNG VENTILATION; MALE; MOUSE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037405097     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00391.2002     Document Type: Article

References (33)

1. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R,/Suter PM. The American-European consensus Conf. on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 157: 1332-1347, 1998.
2. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
3. Bone RC. Multiple system organ failure and the sepsis syndrome. Hosp Pract 26: 101-126, 1991.
4. Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, and Wright JR. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 278: L840-L847, 2000.
5. Brackenbury AM, Malloy JL, McCaig LA, Yao LJ, Veldhuizen RA, and Lewis JF. Evaluation of alveolar surfactant aggregates in vitro and in vivo. Eur Respir J 19: 41-46, 2002.
6. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, and Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342: 1301-1308, 2000.
7. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14: 492-497, 1979.
8. Dunn MS, Shennan AT, Zayack D, and Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics 87: 377-386, 1991.
9. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43: 198-203, 1977.
10. Frerking I, Gunther A, Seeger W, and Pison U. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 27: 1699-1717, 2001.
11. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408: 79-89, 1998.
12. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Maunder RJ, Crim C, and Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976-1981, 1991.
13. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, and Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
14. Lewis JF, Dhillon J, Singh RN, Johnson CC, and Frewen TC. Exogenous surfactant therapy for pediatric patients with the acute respiratory distress syndrome. Can Respir J 4: 21-26, 1997.
15. Lewis JF, Goffin J, Yue P, McCaig LA, Bjarneson D, and Veldhuizen RAW. Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. J Appl Physiol 80: 1156-1164, 1996.
16. Lewis JF and Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 147: 218-233, 1993.
17. Livingston DH, Mosenthal AC, and Deitch EA. Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horiz 3: 257-264, 1995.
18. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 193: 265-275, 1951.
19. Malloy J, McCaig L, Veldhuizen R, Yao LJ, Joseph M, Whitsett J, and Lewis J. Alterations of the endogenous surfactant system in septic adult rats. Am J Respir Crit Care Med 156: 617-623, 1997.
20. Malloy JL, Veldhuizen RA, and Lewis JF. Effects of ventilation on the surfactant system in sepsis-induced lung injury. J Appl Physiol 88: 401-408, 2000.
21. Malloy JL, Veldhuizen RA, McCormack FX, Korfhagen TR, Whitsett JA, and Lewis JF. Pulmonary surfactant and inflammation in septic adult mice: role of surfactant protein A. J Appl Physiol 92: 809-816, 2002.
22. Muscedere JG, Mullen JBM, Gan K, and Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 149: 1327-1334, 1994.
23. Nakamura T, Malloy J, McCaig L, Yao LJ, Joseph M, Lewis J, and Veldhuizen R. Mechanical ventilation of isolated septic rat lungs: effects on surfactant and inflammatory cytokines. J Appl Physiol 91: 811-820, 2001.
24. Pison U, Max M, Neuendank A, Weissbach S, and Pietschmann S. Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system. Eur J Clin Invest 24: 586-599, 1994.
25. Slutsky AS and Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 157: 1721-1725, 1998.
26. Thomassen MJ, Meeker DP, Antal JM, Connors MJ, and Wiedemann HP. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7: 257-260, 1992.
27. Tremblay L, Valenza F, Ribeiro SP, Li J, and Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944-952, 1997.
28. Veldhuizen RA, McCaig LA, Akino T, and Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 152: 1867-1871, 1995.
29. Veldhuizen RA, Welk B, Harbottle R, Hearn S, Nag K, Petersen N, and Possmayer F. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. J Appl Physiol 92: 1169-1175, 2002.
30. Veldhuizen RAW, Slutsky AS, Joseph M, and McCaig L. Effects of mechanical ventilation of isolated mouse lungs on pulmonary surfactant and inflammatory cytokines. Eur Respir J 17: 488-494, 2001.
31. Verbrugge SJ, Vazquez DA, Gommers D, Neggers SJ, Sorm V, Bohm SH, and Lachmann B. Exogenous surfactant preserves lung function and reduces alveolar Evans blue dye influx in a rat model of ventilation-induced lung injury. Anesthesiology 89: 467-474, 1998.
32. Welk B, Malloy JL, Joseph M, Yao LJ, and Veldhuizen RAW. Surfactant treatment for ventilation induced lung injury in rats; effects on lung compliance and cytokines. Exp Lung Res 27: 505-520, 2001.
33. Wright JR and Hawgood S. Pulmonary surfactant metabolism. Clin Chest Med 10: 83-93, 1989.